U.S. drug maker Pfizer Inc. has promised to make changes to its takeover of rival Wyeth in order to win European Union regulatory approval for the deal, the EU's executive said Tuesday.
The European Commission gave no details of any potential selloffs or commitments put forward, merely saying it would extend a deadline to rule on the deal until July 20 to look at changes that aim at soothing antitrust concerns.
New York-based Pfizer, the world's largest pharmaceutical company, launched the $68 billion takeover of Wyeth, of Madison, New Jersey in January. The value of the deal has since declined with Pfizer's share price.
The acquisition is fueled …
No comments:
Post a Comment